Drug intelligence / Profile preview

Children's PediaCare Multi-Symptom Cold

Development stage
Discontinued
Lead developer
Strides Pharma Science
Modality
Small Molecules
Administration
Oral
01

Overview

Children's PediaCare Multi-Symptom Cold is an over-the-counter (OTC) combination medication designed for the temporary relief of symptoms associated with the common cold, flu, and upper respiratory allergies in children aged 4 to 11. The formulation typically includes four active ingredients: acetaminophen (a pain reliever and fever reducer), chlorpheniramine maleate (an antihistamine), dextromethorphan hydrobromide (a cough suppressant), and phenylephrine hydrochloride (a nasal decongestant). Acetaminophen works by inhibiting prostaglandin synthesis in the central nervous system; chlorpheniramine blocks H1 histamine receptors; dextromethorphan acts on the cough center in the medulla to elevate the cough threshold; and phenylephrine is an alpha-1 adrenergic agonist that causes vasoconstriction in the nasal mucosa. While the brand name has been reported as discontinued in the U.S. by some sources, various formulations under the PediaCare umbrella have historically been manufactured and distributed by companies such as Strides Pharma and Fareva Richmond.

Brand names
Children's PediaCare Multi-Symptom ColdPediaCare Multi-Symptom Cold
02

Targets

ADRA1A (α1A)SIGMAR1 (Sigma non-opioid intracellular receptor 1)NMDAR (Glutamate receptor ionotropic, NMDA)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Children's PediaCare Multi-Symptom Cold.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Children's PediaCare Multi-Symptom Cold.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call